amyotrophic-lateral-sclerosis

Documents about amyotrophic-lateral-sclerosis

• The National Amyotrophic Lateral Sclerosis Registry#875404ClinicalTrials.gov
• 3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)#800358ClinicalTrials.gov
• Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)#856009ClinicalTrials.gov
• Chewing Efficiency Measured by a Two Colour Chewing Gum Test in Amyotrophic Lateral Sclerosis (ALS) Patients?#859155ClinicalTrials.gov
• A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS)#874928ClinicalTrials.gov
• A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients#876819ClinicalTrials.gov
• Generation of Cell Banks and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (ALS) (HCD-SLA)#918400ClinicalTrials.gov
• Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis#980761ClinicalTrials.gov
• A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)#866107ClinicalTrials.gov
• Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial#858329ClinicalTrials.gov
• NF-κB Inhibition in Amyotrophic Lateral Sclerosis#832518ClinicalTrials.gov
• Kamlanoflast In Amyotrophic Lateral Sclerosis#874661ClinicalTrials.gov
• Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis#874833ClinicalTrials.gov
• Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis#886525ClinicalTrials.gov
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis#900737ClinicalTrials.gov
• Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study#906411ClinicalTrials.gov
• Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients#910811ClinicalTrials.gov
• A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis#811133ClinicalTrials.gov
• A P300 Brain Computer Interface Keyboard to Control Assistive Technology For Use by People With Amyotrophic Lateral Sclerosis#832836ClinicalTrials.gov
• A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)#886089ClinicalTrials.gov
• Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)#801908ClinicalTrials.gov
• A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)#802889ClinicalTrials.gov
• Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis#849958ClinicalTrials.gov
• Nocturnal PtcCO2 Monitoring in Patients With Amyotrophic Lateral Sclerosis (ALS)#858267ClinicalTrials.gov
• AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis#878064ClinicalTrials.gov
• Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients#908109ClinicalTrials.gov
• Resiliency Intervention for Patients With ALS and Their Care-Partners#993667ClinicalTrials.gov
• Pupil response as a window into cognitive processing in amyotrophic lateral sclerosis#194396HAL (France)
• The Diagnostic Potential of Axon Excitability Is Consistent Across Hand Muscles in Amyotrophic Lateral Sclerosis#253592Europe PMC
• Applications of electromyography in Amyotrophic Lateral Sclerosis: A systematic review#340092HAL (France)
• Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults#804641ClinicalTrials.gov
• Video-Based Proprioceptive Exercise Program in ALS#864081ClinicalTrials.gov
• Detection of Bulbar Involvement in Patients With Amyotrophic Lateral Sclerosis by Machine Learning Voice Analysis: Diagnostic Decision Support Development Study#641702Dipòsit Digital de la Universitat de Barcelona
• Rehabilitative Trial With tDCS in Amyotrophic Lateral Sclerosis#832423ClinicalTrials.gov
• Effect of Motor Rehabilitation Treatment on Amyotrophic Lateral Sclerosis (ALS)#833177ClinicalTrials.gov
• A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)#854669ClinicalTrials.gov
• Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS)#910423ClinicalTrials.gov
• Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials#1007611ClinicalTrials.gov
• Molecular Imaging Modality by Positron Emission Tomography Using 18F-X : Study of Microglial Activation in Amyotrophic Lateral Sclerosis#851128ClinicalTrials.gov
• Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)#885305ClinicalTrials.gov
• Rehabilitation in SOD1 ALS Treated With Tofersen#897650ClinicalTrials.gov
• A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)#915765ClinicalTrials.gov
• Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response#993031ClinicalTrials.gov
• The Emotional Experiences of Healthcare Professionals Working in Amyotrophic Lateral Sclerosis: A Systematic Review#676463Europe PMC
• A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis#827437ClinicalTrials.gov
• A Pilot Study of the Utility of 3D Printed Masks for ALS Subjects#829691ClinicalTrials.gov
• Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS)#895847ClinicalTrials.gov
• Muscle Training of Patients With Amyotrophic Lateral Sclerosis (ALS)#905740ClinicalTrials.gov
• Visualization and Analysis of Mirnas Implicated in Amyotrophic Lateral Sclerosis Within Gene Regulatory Pathways#1027242İzmir Yüksek Teknoloji Enstitüsü
• Time for optimism in amyotrophic lateral sclerosis#384813HAL (France)